The total number of records retrieved from this search are 60. Click on ID to see further detail.

ID	Virus name	Virus strain	Virus genome type	Virus family	Virus genome modification	Virus alone	Virus in combination with drug/radiation	Immune gene insertion in viral genome	Source of cell line	Origin of cell line	Cell line	Concentration of cell line	In-vitro toxicity	Assay	In-vitro virus concentration	In-vitro result	Model organism	In-vivo virus concentration	In-vivo toxicity	In-vivo result	Mode of delivery	Pathway induced	Immunogenic effect	Clinical trial	PMID
OV_861	Herpes simplex virus	BL1	DNA	Herpesviridae	None	Yes	No	No	ATCC	Triple-negative breast cancer cell line	MDA-MB-231	NA	NA	MTT assay	1 MOI	75 % cancerous cell killing after 24 hours	No	No	NA	No response	NA	NA	NA	NA	12595888
OV_864	Herpes simplex virus	BL1	DNA	Herpesviridae	None	Yes	No	No	ATCC	Triple-negative breast cancer cell line	MDA-MB-231	NA	NA	MTT assay	1 MOI	92% cancerous cell killing after 48 hours	No	No	NA	No response	NA	NA	NA	NA	12595888
OV_867	Herpes simplex virus	BL1	DNA	Herpesviridae	None	Yes	No	No	ATCC	Triple-negative breast cancer cell line	MDA-MB-231	NA	NA	MTT assay	0.1 MOI	40 % cancerous cell killing after 24 hours	No	No	NA	No response	NA	NA	NA	NA	12595888
OV_870	Herpes simplex virus	BL1	DNA	Herpesviridae	None	Yes	No	No	ATCC	Triple-negative breast cancer cell line	MDA-MB-231	NA	NA	MTT assay	0.1 MOI	80% cancerous cell killing after 48 hours	No	No	NA	No response	NA	NA	NA	NA	12595888
OV_873	Herpes simplex virus	JS1	DNA	Herpesviridae	None	Yes	No	No	ATCC	Triple-negative breast cancer cell line	MDA-MB-231	NA	NA	MTT assay	1 MOI	85 % cancerous cell killing after 24 hours	No	No	NA	No response	NA	NA	NA	NA	12595888
OV_876	Herpes simplex virus	JS1	DNA	Herpesviridae	None	Yes	No	No	ATCC	Triple-negative breast cancer cell line	MDA-MB-231	NA	NA	MTT assay	1 MOI	96% cancerous cell killing after 48 hours	No	No	NA	No response	NA	NA	NA	NA	12595888
OV_879	Herpes simplex virus	JS1	DNA	Herpesviridae	None	Yes	No	No	ATCC	Triple-negative breast cancer cell line	MDA-MB-231	NA	NA	MTT assay	0.1 MOI	60 % cancerous cell killing after 24 hours	No	No	NA	No response	NA	NA	NA	NA	12595888
OV_882	Herpes simplex virus	JS1	DNA	Herpesviridae	None	Yes	No	No	ATCC	Triple-negative breast cancer cell line	MDA-MB-231	NA	NA	MTT assay	0.1 MOI	88% cancerous cell killing after 48 hours	No	No	NA	No response	NA	NA	NA	NA	12595888
OV_2442	Vaccinia virus	GLV-1h151	DNA	Poxviridae	Deteltion of TK gene and addition of GFP gene	Yes	No	No	ATCC	Human breast cancer cell line	MDA-MB-231	3.0E+4 cells per well	NA	LDH release and spectrophometer	0.01 MOI	100% cell survival after day 1	No	No	NA	No response	NA	NA	NA	NA	22258815
OV_2443	Vaccinia virus	GLV-1h151	DNA	Poxviridae	Deteltion of TK gene and addition of GFP gene	Yes	No	No	ATCC	Human breast cancer cell line	MDA-MB-231	3.0E+4 cells per well	NA	LDH release and spectrophometer	0.01 MOI	100% cell survival after day 3	No	No	NA	No response	NA	NA	NA	NA	22258815
OV_2444	Vaccinia virus	GLV-1h151	DNA	Poxviridae	Deteltion of TK gene and addition of GFP gene	Yes	No	No	ATCC	Human breast cancer cell line	MDA-MB-231	3.0E+4 cells per well	NA	LDH release and spectrophometer	0.01 MOI	100% cell survival after day 5	No	No	NA	No response	NA	NA	NA	NA	22258815
OV_2445	Vaccinia virus	GLV-1h151	DNA	Poxviridae	Deteltion of TK gene and addition of GFP gene	Yes	No	No	ATCC	Human breast cancer cell line	MDA-MB-231	3.0E+4 cells per well	NA	LDH release and spectrophometer	0.01 MOI	100% cell survival after day 7	No	No	NA	No response	NA	NA	NA	NA	22258815
OV_2446	Vaccinia virus	GLV-1h151	DNA	Poxviridae	Deteltion of TK gene and addition of GFP gene	Yes	No	No	ATCC	Human breast cancer cell line	MDA-MB-231	3.0E+4 cells per well	NA	LDH release and spectrophometer	0.01 MOI	100% cell survival after day 9	No	No	NA	No response	NA	NA	NA	NA	22258815
OV_2482	Vaccinia virus	GLV-1h151	DNA	Poxviridae	Deteltion of TK gene and addition of GFP gene	Yes	No	No	ATCC	Human breast cancer cell line	MDA-MB-231	3.0E+4 cells per well	NA	LDH release and spectrophometer	0.10 MOI	90% cell survival after day 1	No	No	NA	No response	NA	NA	NA	NA	22258815
OV_2483	Vaccinia virus	GLV-1h151	DNA	Poxviridae	Deteltion of TK gene and addition of GFP gene	Yes	No	No	ATCC	Human breast cancer cell line	MDA-MB-231	3.0E+4 cells per well	NA	LDH release and spectrophometer	0.10 MOI	90% cell survival after day 3	No	No	NA	No response	NA	NA	NA	NA	22258815
OV_2484	Vaccinia virus	GLV-1h151	DNA	Poxviridae	Deteltion of TK gene and addition of GFP gene	Yes	No	No	ATCC	Human breast cancer cell line	MDA-MB-231	3.0E+4 cells per well	NA	LDH release and spectrophometer	0.10 MOI	90% cell survival after day 5	No	No	NA	No response	NA	NA	NA	NA	22258815
OV_2485	Vaccinia virus	GLV-1h151	DNA	Poxviridae	Deteltion of TK gene and addition of GFP gene	Yes	No	No	ATCC	Human breast cancer cell line	MDA-MB-231	3.0E+4 cells per well	NA	LDH release and spectrophometer	0.10 MOI	90% cell survival after day 7	No	No	NA	No response	NA	NA	NA	NA	22258815
OV_2518	Vaccinia virus	GLV-1h151	DNA	Poxviridae	Deteltion of TK gene and addition of GFP gene	Yes	No	No	ATCC	Human breast cancer cell line	MDA-MB-231	3.0E+4 cells per well	NA	LDH release and spectrophometer	1 MOI	70% cell survival after day 1	No	No	NA	No response	NA	NA	NA	NA	22258815
OV_2519	Vaccinia virus	GLV-1h151	DNA	Poxviridae	Deteltion of TK gene and addition of GFP gene	Yes	No	No	ATCC	Human breast cancer cell line	MDA-MB-231	3.0E+4 cells per well	NA	LDH release and spectrophometer	1 MOI	10% cell survival after day 3	No	No	NA	No response	NA	NA	NA	NA	22258815
OV_2520	Vaccinia virus	GLV-1h151	DNA	Poxviridae	Deteltion of TK gene and addition of GFP gene	Yes	No	No	ATCC	Human breast cancer cell line	MDA-MB-231	3.0E+4 cells per well	NA	LDH release and spectrophometer	1 MOI	10% cell survival after day 5	No	No	NA	No response	NA	NA	NA	NA	22258815
OV_2521	Vaccinia virus	GLV-1h151	DNA	Poxviridae	Deteltion of TK gene and addition of GFP gene	Yes	No	No	ATCC	Human breast cancer cell line	MDA-MB-231	3.0E+4 cells per well	NA	LDH release and spectrophometer	1 MOI	10% cell survival after day 7	No	No	NA	No response	NA	NA	NA	NA	22258815
OV_2579	Adenovirus	CNHK600-IL24	DNA	Adenoviridae	Deletion of E1B gene and addition of IL-24 gene	Yes	No	Virus expressing IL-24 gene	Shanghai laboratory animal center, China	Human breast cancer cell line	MDA-MB-231	1.0E+5 cells per well	NA	MTT assay	0.1 MOI	100% cell survival	No	No	NA	No response	NA	Induction of apoptosis in cancer	NA	NA	22640485
OV_2580	Adenovirus	CNHK600-IL24	DNA	Adenoviridae	Deletion of E1B gene and addition of IL-24 gene	Yes	No	Virus expressing IL-24 gene	Shanghai laboratory animal center, China	Human breast cancer cell line	MDA-MB-231	1.0E+5 cells per well	NA	MTT assay	1 MOI	100% cell survival	No	No	NA	No response	NA	Induction of apoptosis in cancer	NA	NA	22640485
OV_2581	Adenovirus	CNHK600-IL24	DNA	Adenoviridae	Deletion of E1B gene and addition of IL-24 gene	Yes	No	Virus expressing IL-24 gene	Shanghai laboratory animal center, China	Human breast cancer cell line	MDA-MB-231	1.0E+5 cells per well	NA	MTT assay	10 MOI	50% cell survival	No	No	NA	No response	NA	Induction of apoptosis in cancer	NA	NA	22640485
OV_2582	Adenovirus	CNHK600-IL24	DNA	Adenoviridae	Deletion of E1B gene and addition of IL-24 gene	Yes	No	Virus expressing IL-24 gene	Shanghai laboratory animal center, China	Human breast cancer cell line	MDA-MB-231	1.0E+5 cells per well	NA	MTT assay	100 MOI	20% cell survival	No	No	NA	No response	NA	Induction of apoptosis in cancer	NA	NA	22640485
OV_2583	Adenovirus	CNHK600-IL24	DNA	Adenoviridae	Deletion of E1B gene and addition of IL-24 gene	Yes	No	Virus expressing IL-24 gene	Shanghai laboratory animal center, China	Human breast cancer cell line	MDA-MB-231	1.0E+5 cells per well	NA	MTT assay	1000 MOI	10% cell survival	No	No	NA	No response	NA	Induction of apoptosis in cancer	NA	NA	22640485
OV_2584	Adenovirus	CNHK600-IL24	DNA	Adenoviridae	Deletion of E1B gene and addition of IL-24 gene	Yes	No	Virus expressing IL-24 gene	Shanghai laboratory animal center, China	Human breast cancer cell line	MDA-MB-231	1.0E+5 cells per well	NA	MTT assay	10000 MOI	All cells are dead	No	No	NA	No response	NA	Induction of apoptosis in cancer	NA	NA	22640485
OV_2585	Adenovirus	CNHK600-IL24	DNA	Adenoviridae	Deletion of E1B gene and addition of IL-24 gene	Yes	No	Virus expressing IL-24 gene	Shanghai laboratory animal center, China	Human breast cancer cell line	MDA-MB-231	NA	NA	NA	NA	NA	Nu/Nu female mice orthotopic for MDA-MB-231 cell line (8.0E+7 cells)	1.0E+8 pfu	NA	Tumor volume comes to 1000mm as compared to normal 2000 after 42 days	Intratumoral	Induction of apoptosis in cancer	NA	NA	22640485
OV_2586	Adenovirus	CNHK600-IL24	DNA	Adenoviridae	Deletion of E1B gene and addition of IL-24 gene	Yes	No	Virus expressing IL-24 gene	Shanghai laboratory animal center, China	Human breast cancer cell line	MDA-MB-231	NA	NA	NA	NA	NA	Nu/Nu female mice orthotopic for MDA-MB-231 cell line (8.0E+7 cells)	2.0E+8 pfu	NA	Tumor volume comes to below 1000mm as compared to normal 2000 after 42 days	Intratumoral	Induction of apoptosis in cancer	NA	NA	22640485
OV_2587	Adenovirus	CNHK600-IL24	DNA	Adenoviridae	Deletion of E1B gene and addition of IL-24 gene	Yes	No	Virus expressing IL-24 gene	Shanghai laboratory animal center, China	Human breast cancer cell line	MDA-MB-231	NA	NA	NA	NA	NA	Nu/Nu female mice orthotopic for MDA-MB-231 cell line (8.0E+7 cells)	4.0E+8 pfu	NA	Tumor volume comes to 500mm as compared to normal 2000 after 42 days	Intratumoral	Induction of apoptosis in cancer	Upregulation of GADD34	NA	22640485
OV_2632	Adenovirus	SG500-dNK	DNA	Adenoviridae	Addition of deoxyribonucleoside kinase	Yes	No	No	Shanghai cell collection	Human breast cancer cell line	MDA-MB-231	1.0E+4 cells per well	NA	MTT assay	1 MOI	80% cell survival after 3 days	No	No	NA	No response	NA	Combination of drug and virus increase the apoptosis process	NA	NA	23000515
OV_2633	Adenovirus	SG500-dNK	DNA	Adenoviridae	Addition of deoxyribonucleoside kinase	Yes	No	No	Shanghai cell collection	Human breast cancer cell line	MDA-MB-231	1.0E+4 cells per well	NA	MTT assay	1 MOI	60% cell survival after 6 days	No	No	NA	No response	NA	Combination of drug and virus increase the apoptosis process	NA	NA	23000515
OV_2636	Adenovirus	SG500-dNK	DNA	Adenoviridae	Addition of deoxyribonucleoside kinase	No	Virus in combination with drug Bvdu (1 micromolar)	No	Shanghai cell collection	Human breast cancer cell line	MDA-MB-231	1.0E+4 cells per well	NA	MTT assay	1 MOI	70% cell survival after 3 days	No	No	NA	No response	NA	Combination of drug and virus increase the apoptosis process	NA	NA	23000515
OV_2637	Adenovirus	SG500-dNK	DNA	Adenoviridae	Addition of deoxyribonucleoside kinase	No	Virus in combination with drug Bvdu (1 micromolar)	No	Shanghai cell collection	Human breast cancer cell line	MDA-MB-231	1.0E+4 cells per well	NA	MTT assay	1 MOI	30% cell survival after 6 days	No	No	NA	No response	NA	Combination of drug and virus increase the apoptosis process	NA	NA	23000515
OV_2638	Adenovirus	SG500-dNK	DNA	Adenoviridae	Addition of deoxyribonucleoside kinase	No	Virus in combination with drug dFdC (1 micromolar)	No	Shanghai cell collection	Human breast cancer cell line	MDA-MB-231	1.0E+4 cells per well	NA	MTT assay	1 MOI	60% cell survival after 3 days	No	No	NA	No response	NA	Combination of drug and virus increase the apoptosis process	NA	NA	23000515
OV_2639	Adenovirus	SG500-dNK	DNA	Adenoviridae	Addition of deoxyribonucleoside kinase	No	Virus in combination with drug dFdC (1 micromolar)	No	Shanghai cell collection	Human breast cancer cell line	MDA-MB-231	1.0E+4 cells per well	NA	MTT assay	1 MOI	20% cell survival after 6 days	No	No	NA	No response	NA	Combination of drug and virus increase the apoptosis process	NA	NA	23000515
OV_2644	Adenovirus	SG500-dNK	DNA	Adenoviridae	Addition of deoxyribonucleoside kinase	No	Virus in combination with drug Bvdu (1 micromolar)	No	Shanghai cell collection	Human breast cancer cell line	MDA-MB-231	1.0E+4 cells per well	NA	MTT assay	0.001 MOI	80% cell survival	No	No	NA	No response	NA	Combination of drug and virus increase the apoptosis process	NA	NA	23000515
OV_2645	Adenovirus	SG500-dNK	DNA	Adenoviridae	Addition of deoxyribonucleoside kinase	No	Virus in combination with drug Bvdu (1 micromolar)	No	Shanghai cell collection	Human breast cancer cell line	MDA-MB-231	1.0E+4 cells per well	NA	MTT assay	0.01 MOI	80% cell survival	No	No	NA	No response	NA	Combination of drug and virus increase the apoptosis process	NA	NA	23000515
OV_2646	Adenovirus	SG500-dNK	DNA	Adenoviridae	Addition of deoxyribonucleoside kinase	No	Virus in combination with drug Bvdu (1 micromolar)	No	Shanghai cell collection	Human breast cancer cell line	MDA-MB-231	1.0E+4 cells per well	NA	MTT assay	0.1 MOI	60% cell survival	No	No	NA	No response	NA	Combination of drug and virus increase the apoptosis process	NA	NA	23000515
OV_2647	Adenovirus	SG500-dNK	DNA	Adenoviridae	Addition of deoxyribonucleoside kinase	No	Virus in combination with drug Bvdu (1 micromolar)	No	Shanghai cell collection	Human breast cancer cell line	MDA-MB-231	1.0E+4 cells per well	NA	MTT assay	1 MOI	50% cell survival	No	No	NA	No response	NA	Combination of drug and virus increase the apoptosis process	NA	NA	23000515
OV_2648	Adenovirus	SG500-dNK	DNA	Adenoviridae	Addition of deoxyribonucleoside kinase	No	Virus in combination with drug Bvdu (1 micromolar)	No	Shanghai cell collection	Human breast cancer cell line	MDA-MB-231	1.0E+4 cells per well	NA	MTT assay	10 MOI	40% cell survival	No	No	NA	No response	NA	Combination of drug and virus increase the apoptosis process	NA	NA	23000515
OV_2649	Adenovirus	SG500-dNK	DNA	Adenoviridae	Addition of deoxyribonucleoside kinase	No	Virus in combination with drug dFdC (1 micromolar)	No	Shanghai cell collection	Human breast cancer cell line	MDA-MB-231	1.0E+4 cells per well	NA	MTT assay	0.001 MOI	80% cell survival	No	No	NA	No response	NA	Combination of drug and virus increase the apoptosis process	NA	NA	23000515
OV_2650	Adenovirus	SG500-dNK	DNA	Adenoviridae	Addition of deoxyribonucleoside kinase	No	Virus in combination with drug dFdC (1 micromolar)	No	Shanghai cell collection	Human breast cancer cell line	MDA-MB-231	1.0E+4 cells per well	NA	MTT assay	0.01 MOI	70% cell survival	No	No	NA	No response	NA	Combination of drug and virus increase the apoptosis process	NA	NA	23000515
OV_2651	Adenovirus	SG500-dNK	DNA	Adenoviridae	Addition of deoxyribonucleoside kinase	No	Virus in combination with drug dFdC (1 micromolar)	No	Shanghai cell collection	Human breast cancer cell line	MDA-MB-231	1.0E+4 cells per well	NA	MTT assay	0.1 MOI	40% cell survival	No	No	NA	No response	NA	Combination of drug and virus increase the apoptosis process	NA	NA	23000515
OV_2652	Adenovirus	SG500-dNK	DNA	Adenoviridae	Addition of deoxyribonucleoside kinase	No	Virus in combination with drug dFdC (1 micromolar)	No	Shanghai cell collection	Human breast cancer cell line	MDA-MB-231	1.0E+4 cells per well	NA	MTT assay	1 MOI	20% cell survival	No	No	NA	No response	NA	Combination of drug and virus increase the apoptosis process	NA	NA	23000515
OV_2653	Adenovirus	SG500-dNK	DNA	Adenoviridae	Addition of deoxyribonucleoside kinase	No	Virus in combination with drug dFdC (1 micromolar)	No	Shanghai cell collection	Human breast cancer cell line	MDA-MB-231	1.0E+4 cells per well	NA	MTT assay	10 MOI	10% cell survival	No	No	NA	No response	NA	Combination of drug and virus increase the apoptosis process	NA	NA	23000515
OV_2664	Adenovirus	SG500-dNK	DNA	Adenoviridae	Addition of deoxyribonucleoside kinase	No	Virus in combination with drug dFdC (1 micromolar)	No	Shanghai cell collection	Human breast cancer cell line	MDA-MB-231	NA	NA	NA	NA	NA	BALB/c nude mice xenograft for MDA-MB-231(5.0E+6 cells)	1.0E+9 pfu	NA	Increase in median survival time to more than 100 days compared to control and reduction in tumor volume 663.85 +/- 379.39mm compared to control 1336.46 +/- 614.81	NA	Combination of drug and virus increase the apoptosis process	NA	NA	23000515
OV_2938	Newcastle disease virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	ATCC	Human mammary cancer cell line	MDA-MB-231	1.0E+4 cells per well	NA	MTT assay	2⁴.⁷ HAU/ml	Cell viability reduced below 20%	No	No	NA	No response	NA	Induction of apoptosis as measured by TUNEL assay (44.52 +/- 10.13) after 72 hours	NA	NA	25821783
OV_4301	Alphavirus	M1	RNA	Togaviridae	None	Yes	No	No	ATCC	Human breast adenocarcinoma	MDA-MB-231	4000 cells per well	NA	MTT assay	10 pfu	58.9 % cell viability after 72 hours	No	No	NA	No response	NA	Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis	NA	NA	26373347
OV_5043	Vaccinia virus	VG9	DNA	Poxviridae	None	Yes	No	No	ATCC	Human breast adenocarcinoma cell line	MDA-MB-231	1.0E+4 cells per well	NA	MTT assay	0.1 MOI	40% cell viability after 3 days	No	No	NA	No response	NA	NA	NA	NA	28465492
OV_5044	Vaccinia virus	VG9	DNA	Poxviridae	None	Yes	No	No	ATCC	Human breast adenocarcinoma cell line	MDA-MB-231	1.0E+4 cells per well	NA	MTT assay	1 MOI	30% cell viability after 3 days	No	No	NA	No response	NA	NA	NA	NA	28465492
OV_5045	Vaccinia virus	VG9	DNA	Poxviridae	None	Yes	No	No	ATCC	Human breast adenocarcinoma cell line	MDA-MB-231	1.0E+4 cells per well	NA	MTT assay	10 MOI	20% cell viability after 3 days	No	No	NA	No response	NA	NA	NA	NA	28465492
OV_5046	Vaccinia virus	VG9-EGFP	DNA	Poxviridae	Addition of EGFP gene in tk locus	Yes	No	No	ATCC	Human breast adenocarcinoma cell line	MDA-MB-231	1.0E+4 cells per well	NA	MTT assay	0.1 MOI	30% cell viability after 3 days	No	No	NA	No response	NA	NA	NA	NA	28465492
OV_5047	Vaccinia virus	VG9-EGFP	DNA	Poxviridae	Addition of EGFP gene in tk locus	Yes	No	No	ATCC	Human breast adenocarcinoma cell line	MDA-MB-231	1.0E+4 cells per well	NA	MTT assay	1 MOI	30% cell viability after 3 days	No	No	NA	No response	NA	NA	NA	NA	28465492
OV_5048	Vaccinia virus	VG9-EGFP	DNA	Poxviridae	Addition of EGFP gene in tk locus	Yes	No	No	ATCC	Human breast adenocarcinoma cell line	MDA-MB-231	1.0E+4 cells per well	NA	MTT assay	10 MOI	20% cell viability after 3 days	No	No	NA	No response	NA	NA	NA	NA	28465492
OV_5049	Vaccinia virus	WR-EGFP	DNA	Poxviridae	Addition of EGFP gene in tk locus	Yes	No	No	ATCC	Human breast adenocarcinoma cell line	MDA-MB-231	1.0E+4 cells per well	NA	MTT assay	0.1 MOI	30% cell viability after 3 days	No	No	NA	No response	NA	NA	NA	NA	28465492
OV_5050	Vaccinia virus	WR-EGFP	DNA	Poxviridae	Addition of EGFP gene in tk locus	Yes	No	No	ATCC	Human breast adenocarcinoma cell line	MDA-MB-231	1.0E+4 cells per well	NA	MTT assay	1 MOI	30% cell viability after 3 days	No	No	NA	No response	NA	NA	NA	NA	28465492
OV_5051	Vaccinia virus	WR-EGFP	DNA	Poxviridae	Addition of EGFP gene in tk locus	Yes	No	No	ATCC	Human breast adenocarcinoma cell line	MDA-MB-231	1.0E+4 cells per well	NA	MTT assay	10 MOI	20% cell viability after 3 days	No	No	NA	No response	NA	NA	NA	NA	28465492
OV_5377	Maraba virus	MG1	RNA	Rhabdoviridae	None	Yes	No	No	ATCC	Human triple negative breast cancer cell line	MDA-MB-231	NA	NA	Coomassie brilinat blue staining	4 micromolar	80% cell viable after 48 hours	No	No	NA	No response	NA	Induction of apoptosis	NA	In clinical trial for various cancer cell line	27503504
OV_5380	Maraba virus	MG1	RNA	Rhabdoviridae	None	No	Virus in combination with 2 micromolar palcitaxel for 48 hours	No	ATCC	Human triple negative breast cancer cell line	MDA-MB-231	NA	NA	Coomassie brilinat blue staining	4 micromolar	30% cell viability after 48 hours	No	No	NA	No response	NA	Induction of apoptosis	Level of IFN beta production does not effected by combination	In clinical trial for various cancer cell line	27503504